Log in
Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery
Phase 2
Completed
Conditions
Deep Venous Thrombosis
Interventions
Drug: Desirudin (Iprivask™)
Drug: Heparin
Subscribe
First Posted Date
2006-05-24
Last Posted Date
2019-03-05
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
120
Registration Number
NCT00329433
Locations
🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy